← Open Payments lookup

KIMBERLY VELIE: Open Payments

NPI 1275109605 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$653 in 32 payments from 10 companies in 2025. Trend: 2023 $211 · 2024 $99 · 2025 $653

Food & beverage: $653
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$243
Vanda Pharmaceuticals Inc.7$151
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$76
ABBVIE INC.3$53
Otsuka Pharmaceutical Development & Commercialization, Inc.1$29
Axsome Therapeutics, Inc.1$27
Biogen, Inc.1$26
JAZZ PHARMACEUTICALS INC.1$17
Janssen Pharmaceuticals, Inc1$16
Neurocrine BioSciences, Inc.1$14

Products named: REXULTI, FANAPT, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, REJOYN, Auvelity, LEQEMBI.

Industry payments across AL — which companies pay providers there.